26 related articles for article (PubMed ID: 38439715)
21. DNA methylation heterogeneity attributable to a complex tumor immune microenvironment prompts prognostic risk in glioma.
Ma S; Pan X; Gan J; Guo X; He J; Hu H; Wang Y; Ning S; Zhi H
Epigenetics; 2024 Dec; 19(1):2318506. PubMed ID: 38439715
[TBL] [Abstract][Full Text] [Related]
22. Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution.
Bao Z; Wang Y; Wang Q; Fang S; Shan X; Wang J; Jiang T
Front Med; 2021 Aug; 15(4):551-561. PubMed ID: 33893983
[TBL] [Abstract][Full Text] [Related]
23. Molecular diversity in isocitrate dehydrogenase-wild-type glioblastoma.
Fares J; Wan Y; Mair R; Price SJ
Brain Commun; 2024; 6(2):fcae108. PubMed ID: 38646145
[TBL] [Abstract][Full Text] [Related]
24. GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity.
Vartanian A; Singh SK; Agnihotri S; Jalali S; Burrell K; Aldape KD; Zadeh G
Neuro Oncol; 2014 Sep; 16(9):1167-75. PubMed ID: 24642524
[TBL] [Abstract][Full Text] [Related]
25. Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia-Glioma Cross-Talk.
Altieri R; Barbagallo D; Certo F; Broggi G; Ragusa M; Di Pietro C; Caltabiano R; Magro G; Peschillo S; Purrello M; Barbagallo G
Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33561993
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
